HESG (Health Sciences Group) Cash Flow from Financing: $0.08 Mil (TTM As of Sep. 2006)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Health Sciences Group Cash Flow from Financing?

Health Sciences Group HESG -99.00% Cash Flow from Financing is $0.08 Mil as of Sep. 2006.

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2006, Health Sciences Group paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.04 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Health Sciences Group earned $0.04 Mil on financial activities for the three months ended in Sep. 2006.


Health Sciences Group  (OTCPK:HESG) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Health Sciences Group's issuance of stock for the three months ended in Sep. 2006 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Health Sciences Group's repurchase of stock for the three months ended in Sep. 2006 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Health Sciences Group's net issuance of debt for the three months ended in Sep. 2006 was $0.04 Mil. Health Sciences Group received $0.04 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Health Sciences Group's net issuance of preferred for the three months ended in Sep. 2006 was $0.00 Mil. Health Sciences Group paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Health Sciences Group's cash flow for dividends for the three months ended in Sep. 2006 was $0.00 Mil. Health Sciences Group received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Health Sciences Group's other financing for the three months ended in Sep. 2006 was $0.00 Mil. Health Sciences Group received $0.00 Mil on other financial activities.


Health Sciences Group Cash Flow from Financing Related Terms


Health Sciences Group Cash Flow from Financing Historical Data

* Premium members only.

The historical data trend for Health Sciences Group's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Sciences Group Cash Flow from Financing Chart

Health Sciences Group Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
Cash Flow from Financing
Get a 7-Day Free Trial 0.46 0.78 1.58 0.82 3.68

Health Sciences Group Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.09 0.11 0.02 0.04

Health Sciences Group Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Health Sciences Group's Cash from Financing for the fiscal year that ended in Dec. 2005 is calculated as:

Health Sciences Group's Cash from Financing for the quarter that ended in Sep. 2006 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2006 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Financing of $0.08 Mil mean?
Health Sciences Group (HESG) has a Cash Flow from Financing of $0.08 Mil as of Sep. 2006. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Health Sciences Group and its competitors.
Is Health Sciences Group's Cash Flow from Financing too high?
Health Sciences Group's current Cash Flow from Financing is $0.08 Mil.
How does Health Sciences Group's Cash Flow from Financing compare to VITIF and HSTC?
Health Sciences Group's Cash Flow from Financing of $0.08 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Biotechnology company?
A good Cash Flow from Financing depends on the Biotechnology industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Health Sciences Group and its competitors. Health Sciences Group's current Cash Flow from Financing is $0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Sciences Group stock overvalued right now?
Health Sciences Group (HESG) has a current Cash Flow from Financing of $0.08 Mil. The current Cash Flow from Financing is $0.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Health Sciences Group (HESG), the current Cash Flow from Financing is $0.08 Mil as of Sep. 2006. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Sciences Group Business Description

Address 14331 Euclid Street, Suite 207, Garden Grove, CA, USA, 92843
Health Sciences Group Inc identifies, develops, and commercializes nutritional products. Its products are targeted towards consumers and medical professionals interested in preventative healthcare alternatives. The products are sold as nutritional supplements and functional ingredients to retail and wholesale customers in the nutrition, skin care, and food industries. The company distributes its products under the Swiss Research and Swiss Diet brand names.